Iowa needs collaboration, not new bachelor's degree programs | Opinion

Great examples already exist of cooperation expanding access; that should be the model instead of costly redundancy, writes .

Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

The newly established CAB has been formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The CAB ...
JD Supra

ITAR Law and Compliance in Practice Trade

The International Traffic in Arms Regulations (ITAR) set the rules for how defense-related items, services, and technical ...

Eagle Plains Reports up to 427g/t Au at the Pine Channel Gold Project, Saskatchewan

CRANBROOK, BRITISH COLUMBIA / ACCESS Newswire / January 15, 2026 / Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ...
Yahoo Finance

IsoEnergy Initiates Bulk Sample Program at the Tony M Uranium Mine in Utah, a Key Step Toward a Potential Restart Decision

TORONTO, Jan. 7, 2026 /CNW/ - IsoEnergy Ltd. ("IsoEnergy" or the "Company") (NYSE American: ISOU) (TSX: ISO) is pleased to announce a bulk sample program (the "Bulk Sample") at its 100%-owned Tony M ...
Durham Region

‘Unable to function’: Driver with breath sample nearly 6 times legal limit among 15 charged with drunk driving in 3rd week of Durham RIDE program, say police

Durham police took a driver to the hospital after they blew nearly six times the legal limit — one of 15 people charged with impaired driving during the third week of a holiday RIDE program. “Officers ...
Seeking Alpha

Structure Therapeutics Reports Positive Topline Data from ACCESS Program for its Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Yahoo Finance

Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...